14-day Premium Trial Subscription Sign Up For FreeGet Free

$3.07 (-2.54%)

Volume: 2M

Closed: Jan 21, 2022

Hollow Logo Score: -5.182

Curis Stock Forecast

$3.07 (-2.54%)

Volume: 2M

Closed: Jan 21, 2022

Score Hollow Logo -5.182

CRIS Stock Insider Trading NASDAQ:CRIS

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 92.261.

In total, the insiders bought 26 708 736 and sold 722 901 CRIS shares in the last 100 trades.

INSIDER POWER

92.261

Last 100 transactions
Buy: 26 708 736 | Sell: 722 901 (Shares)
Date Action Amount Person Type
Dec 02, 2021 Buy 25 000 Hohneker John Non Qualified Stock Option
Jan 28, 2021 Buy 180 000 Steinkrauss William Employee stock option (right to buy)
Jan 28, 2021 Buy 33 000 Rubin Marc Non Qualified Stock Option
Jan 28, 2021 Buy 126 000 Martell Robert Employee stock option (right to buy)
Jan 28, 2021 Buy 33 000 Kaitin Kenneth I Non Qualified Stock Option
Jan 28, 2021 Buy 330 000 Dentzer James E Employee stock option (right to buy)
Jan 28, 2021 Buy 33 000 Kunkel Lori Anne Non Qualified Stock Option
Jan 28, 2021 Buy 33 000 Greenacre Martyn D Non Qualified Stock Option
Jan 26, 2021 Sell 3 094 Dentzer James E Common Stock
Jan 25, 2021 Sell 2 283 Dentzer James E Common Stock
Mar 02, 2020 Buy 180 000 Kunkel Lori Anne Non Qualified Stock Option
Mar 02, 2020 Buy 180 000 Kaitin Kenneth I Non Qualified Stock Option
Mar 02, 2020 Buy 180 000 Rubin Marc Non Qualified Stock Option
Mar 02, 2020 Buy 385 000 Martell Robert Employee stock option (right to buy)
Mar 02, 2020 Buy 385 000 Steinkrauss William Employee stock option (right to buy)
Mar 02, 2020 Buy 750 000 Dentzer James E Employee stock option (right to buy)
Mar 02, 2020 Buy 180 000 Greenacre Martyn D Non Qualified Stock Option
Feb 02, 2020 Buy 152 286 Passeri Daniel R Non-qualified stock option (right to buy)
Jan 24, 2020 Sell 3 094 Dentzer James E Common Stock
Jan 23, 2020 Sell 3 658 Dentzer James E Common Stock
Sep 10, 2019 Buy 125 000 Steinkrauss William Employee stock option (right to buy)
May 23, 2019 Buy 386 996 Martell Robert Employee stock option (right to buy)
May 23, 2019 Buy 1 115 871 Dentzer James E Employee stock option (right to buy)
Jan 24, 2019 Sell 3 094 Dentzer James E Common Stock
Jan 23, 2019 Sell 18 500 Greenacre Martyn D Common Stock
Jan 23, 2019 Sell 5 500 Martell Robert Common Stock
Jan 23, 2019 Sell 8 473 Martell Robert Common Stock
Jan 23, 2019 Sell 18 500 Rubin Marc Common Stock
Jan 23, 2019 Sell 14 800 Kaitin Kenneth I Common Stock
Jan 23, 2019 Sell 14 800 Kunkel Lori Anne Common Stock
INSIDER POWER

92.261

Last 100 transactions
Buy: 26 708 736 | Sell: 722 901 (Shares)

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers. The company develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase II clinical trials for advanced lymphomas and multiple myeloma. It also develops CUDC-427 that has completed Phase I clinical trials for advanced solid tumor and lympho... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT